Wall Street May Be Mispricing Medtronic, Analyst Says

On Wednesday, Medtronic plc (NYSE:MDT) reported fourth-quarter revenue that exceeded Wall Street expectations, supported by strong growth in its Cardiovascular and Diabetes businesses. Earnings Beat Expectations Adjusted earnings came in at $1.55 per share, slightly...